Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
4.920
-0.040 (-0.81%)
At close: Mar 12, 2026, 4:00 PM EDT
4.970
+0.050 (1.02%)
After-hours: Mar 12, 2026, 5:50 PM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $534.16 million as of March 12, 2026. Its market cap has decreased by -37.39% in one year.
Market Cap
534.16M
Enterprise Value
372.82M
1-Year Change
-37.39%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $534.16M, an increase of 460.50%. That is a compound annual growth rate of 16.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 538.50M | 41.75% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 559.29M |
| Immix Biopharma | 551.20M |
| Vanda Pharmaceuticals | 549.11M |
| Verastem | 543.70M |
| YD Bio | 541.81M |
| Invivyd | 536.93M |
| Lyell Immunopharma | 534.07M |
| CorMedix | 528.85M |